294 related articles for article (PubMed ID: 10934805)
1. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.
Hwang SJ; Luo JC; Lai CR; Chu CW; Tsay SH; Lu CL; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):527-35. PubMed ID: 10934805
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
3. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
4. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
6. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C.
Benini F; Pigozzi MG; Baisini O; Romanini L; Ahmed H; Pozzi A; Ricci C; Lanzini A
J Gastroenterol Hepatol; 2007 Oct; 22(10):1621-6. PubMed ID: 17845689
[TBL] [Abstract][Full Text] [Related]
7. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
8. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
9. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
10. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
11. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.
Rai R; Wilson LE; Astemborski J; Anania F; Torbenson M; Spoler C; Vlahov D; Strathdee SA; Boitnott J; Nelson KE; Thomas DL
Hepatology; 2002 May; 35(5):1247-55. PubMed ID: 11981775
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
16. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
[TBL] [Abstract][Full Text] [Related]
17. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
18. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
20. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
